Intravenous Dexamethasone and intravenous lidocaine in children undergoing cleft palate surgery

A comparative study on the effect of intravenous dexamethasone and intravenous lidocaine on reduction of hemodynamic and respiratory complications in children undergoing cleft palate surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160301026866N8

Enrollment

115

Registered

2018-09-17

Start date

2018-09-20

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory and hemodynamic complications in the cleft palate. Cleft palate

Interventions

Intervention 1: Intervention group 1: Before induction of anesthesia, a recovery nurse will be administered to the first group of intravenous dexamethasone (0.2 mg / kg). Intervention 2: Intervention

Eligibility

Sex/Gender

All

Age

6 Months to 2 Years

Inclusion criteria

Inclusion criteria: Six months to two years children with ASA class I and II without underlying illness candidate for Cleft palate surgery

Exclusion criteria

Exclusion criteria: The presence of symptoms of upper respiratory tract infection Coagulation disorder Systemic diseases other hereditary abnormalities

Design outcomes

Primary

Measure	Time frame
Mean arterial blood pressure. Timepoint: Every 15 minutes during surgery and every 15 minutes in recovery room. Method of measurement: Anesthetic monitoring device.;Heart rate. Timepoint: Every 15 minutes during surgery and every 15 minutes in recovery room. Method of measurement: Anesthetic monitoring device.;Respiratory complications(Larangospasm, bronchospasm, coughing). Timepoint: in the recovery room. Method of measurement: Recording the complications.;Intensity of pain. Timepoint: Every 15 minutes in recovery room. Method of measurement: Visual Analogue Scale.	—

Measure

Time frame

Mean arterial blood pressure. Timepoint: Every 15 minutes during surgery and every 15 minutes in recovery room. Method of measurement: Anesthetic monitoring device.;Heart rate. Timepoint: Every 15 minutes during surgery and every 15 minutes in recovery room. Method of measurement: Anesthetic monitoring device.;Respiratory complications(Larangospasm, bronchospasm, coughing). Timepoint: in the recovery room. Method of measurement: Recording the complications.;Intensity of pain. Timepoint: Every 15 minutes in recovery room. Method of measurement: Visual Analogue Scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Shafa

Esfahan University of Medical Sciences

shafa_amir@yahoo.com+98 31 3773 5509

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026